OARS funding Aging

This Funding Opportunity Announcement (FOA) solicits Edward R. Roybal Centers for Translation Research in the Behavioral and Social Sciences of Aging. Center resources are intended for the development and piloting of new and innovative ideas for early stage as well as late stage translation of basic behavioral and social research findings about established or hypothesized mechanisms of action, at the individual or population level, into programs and practices that will improve the lives of older people and the capacity of institutions to adapt to societal aging.

The National Institute on Aging invites the submission of investigator-initiated program project (P01) applications. The applications should address scientific areas relevant to the NIA mission. Each P01 application submitted to this FOA must include at least three related research projects that share a common central theme, focus, and/overall objective and an administrative core to lead the project.

The purpose of this FOA is to disseminate and implement existing evidence for improving the quality of health care delivery. Applicants are required to demonstrate the ability and commitment to leverage the capacities of existing broad-based networks of providers and other key stakeholders in their dissemination and implementation activities.

The National Institute on Aging (NIA) invites applications for a clinical trial on effects of vitamin D supplementation on falls and gait speed in older individuals. During the six-year support period, the awardee will implement a randomized controlled trial with sufficient power to determine the dose-response and efficacy of vitamin D supplementation in preventing falls, across a range of doses and baseline vitamin D levels.  A measurement of effects of supplementation on gait speed should be proposed as a secondary outcome.  Applicants are strongly encouraged to consider advanced, cost-efficient designs that include a dose-ranging phase followed by an efficacy phase for select doses (e.g., adaptive designs). The first nine months of the award will provide funds to conduct pilot studies to test recruitment strategies, determine the proportion of those screened who are both eligible and willing to be randomized, and finalize the study protocol, data collection forms and manual of procedures for the trial. 

AAAS offers fellowships in nine programmatic areas. Specific host offices and assignments vary from year to year. Congressional Diplomacy, Security& Development Energy, Environment & Agriculture Health, Education & Human Services Big Data & Analytics Judicial Branch Roger Revelle Fellowship in Global Stewardship AAAS Overseas Fellowships at USAID Missions (limited eligibility) Global Health & Development Fellowships (limited eligibility)

The purpose of this funding opportunity announcement (FOA) issued by the National Institute on Aging (NIA) is to solicit two-year Research Project Grant (R01) applications that propose to explore the potential for midlife plasticity of biobehavioral or psychological systems affected by early life disadvantage. In order to speed the development of novel intervention strategies, applicants are encouraged either to use existing human cohort data to identify circumstances that mitigate or exacerbate the effects of early adversity or to use human and/or animal models to test the feasibility of developing interventions aimed specifically at increasing malleability in adulthood of risk persistence mechanisms.

The purpose of this funding opportunity announcement (FOA) issued by the National Institute on Aging (NIA), working in part with funds contributed by the NIH Office of Behavioral and Social Sciences Research (http://obssr.od.nih.gov/index.aspx ), is to provide infrastructure support for advancing development of specific emerging and high priority interdisciplinary areas of behavioral and social research of relevance to aging. The infrastructure support will facilitate research networks through meetings, conferences, small scale pilots, training, and dissemination to encourage growth and development of specified priority areas and of resources for the field at large. Projects are solicited that will develop, strengthen, and evaluate transdisciplinary approaches and methods for basic behavioral and/or social research.

The purpose of this Funding Opportunity Announcement (FOA) is to solicit innovative social, behavioral, health services, and policy research that can directly and demonstrably contribute to the elimination of health disparities. Projects may involve primary data collection or secondary analysis of existing datasets. Projects that examine understudied health conditions; examine the effectiveness of interventions, services, or policies for multiple health disparity populations; and/or directly measure the impact of project activities on levels of health disparities are particularly encouraged.

The purpose of this FOA is to provide network and infrastructure support to foster development of novel interdisciplinary research approaches on aging research related to multiple chronic conditions (MCCs). This FOA uses the Resource-Related Research Project activity code (R24) to support research networks that will advance interdisciplinary collaboration through activities such as meetings, conferences, data exchange, small scale pilots, short term training opportunities, visiting scholar programs and dissemination activities to encourage growth and development in the science related to older adults with MCCs.

This Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.

Our nation's health delivery system frequently does not meet the unique needs of older adults. Wide gaps remain between evidence-based approaches, nationally recognized best practices, and how care is currently delivered for many conditions that disproportionately affect this population. Strong leadership is needed to ensure that promising innovations are implemented to improve health and functional outcomes in older adults. The Practice Change Leaders program is a one-year opportunity to gain enhanced leadership skills and content expertise to positively influence care for older adults. Leaders complete a project aimed at integrating improved care for older adults within their organization, allowing them to remain at their full time job throughout the one-year program.

The purpose of this FOA is to stimulate the development of innovative research strategies aimed at increasing the understanding of the molecular and cellular changes in the cytoskeleton that occur during the aging process.  Applications considering the effect of age on factors such as cytoskeleton structure and function, the impact of the cytoskeleton on intracellular organelle interactions, and signaling or regulatory molecules controlling cellular architecture are encouraged.  There is also interest in studying the role of the cytoskeleton in nuclear-cytoplasmic communications, and in spatio-temporal relationships during the aging process and in age-related diseases.

The purpose of the Aging Interventions Testing Program (ITP) is to test, under standardized conditions in multiple sites, potential intervention strategies which may decelerate the rate of aging in mammals. The rate of aging is to be measured by lifespan extension and/or improvements in health at later ages due to the intervention. The ITP has used life span as its primary outcome for an intervention, with limited studies on end-of-life pathologies and selected tests of health across the lifespan (health span). This FOA calls for renewal and expansion of the ITP with the following goals: 1. Continue to test compounds for effects on lifespan; 2. Increase analysis of pharmacodynamics and pharmacokinetics of compounds proposed for lifespan studies, including studies of optimal effective dose; 3. Increase histology and pathophysiology analyses at time-of-death; 4. Increase focused studies of health span on selected compounds; 5. Establish a data coordinating center.

Calling all postdoctoral trainees, graduate students, and junior faculty from geriatric programs, aging institutes, and medical schools: submit your late breaker abstract for the opportunity for a travel award funded by NIA. GSA will select up to 10 travel awards, each in the amount of $900 and complimentary registration to attend and participate in the workshop for faculty and research fellows will be made to help defray the cost of attending GSA's Annual Scientific Meeting.  All attendees are expected to stay and participate in the entire workshop. For more information, such as who is eligible and how to apply, click here or contact jlieu@geron.org. Poster and application are due by September 15, 2013

This award honors an individual whose work has made significant early career contributions to understanding critical issues in the psychology of adult development and aging. The recipient will be presented with a plaque and a cash award at the Division 20 Business Meeting during the annual APA convention in the year the award is received.

The recipient will be recognized at the annual meeting of the Division of Adult Development and Aging. Candidates are welcome from any area of the psychology of aging and adult development. The recipient will be presented with a plaque and a cash award at the Division 20 Business Meeting during the annual APA convention in the year the award is received.

The Mentor award will be presented to an individual who has consistently provided support, guidance, and strong direction to undergraduate and graduate students in aging and adult development. This individual might be someone who resides at a liberal arts institution or college that focuses on undergraduate education or it may be an individual at a PhD-granting institution. This award will be given to the individual who has been most actively committed to mentoring and who best exemplifies the qualities identified with strong, effective mentoring.

This Funding Opportunity Announcement (FOA) solicits Research and Development Center (P30) grant applications in the areas of demography and economics of aging, including relevant interdisciplinary areas rooted in population-based social science research. Center grant applications must include two mandatory Cores and may choose among four optional Cores.

Grants of up to $20,000 are available to help support the research of faculty members or post-doctoral researchers affiliated with non-profit human service organizations in the United States and Canada. Areas of interest to the Fund are: studies to develop, refine, evaluate, or disseminate innovative interventions designed to prevent or ameliorate major social, psychological, behavioral or public health problems affecting children, adults, couples, families, or communities, or studies that have the potential for adding significantly to knowledge about such problems. The research for which funding is requested must focus on the United States or Canada or on a comparison between the United States or Canada and one or more other countries.

With this FOA, AHRQ is investing in the adaptation, refinement or development of research methods that will enhance our understanding of how to provide high-quality health care for patients with MCC.   Applicants must: 1.  Propose an adaptation or refinement to existing methodology or propose the development of a new methodology for studying people with MCC 2.  Validate and assess the proposed methodology  Examples of potential methodological projects include, but are not limited to: developing and using clear conceptual models to conduct foundational research into health and health care for people with MCC, developing and validating relevant outcomes for this priority population group, specifying combinations of chronic conditions that are of clinical interest and relevance, accurately measuring co-morbidities and stratifying by disease severity status, addressing issues related to  quasi experimental design with large sample sizes for  understanding the heterogeneity of treatment effects.